RecruitingPhase 4NCT06367855
Efficacy and Safety of Preemptive Intravenous Dexamethasone in MIS-TLIF
Sponsor
Potsawat Surabotsopon
Enrollment
60 participants
Start Date
May 1, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
Researchers are considering Dexamethasone as preemptive medication before minimally invasive spine fusion surgery to minimize postoperative back pain with minimal side effects, aiming to enhance the effectiveness of surgery and improve patient outcomes.
Eligibility
Min Age: 50 YearsMax Age: 80 Years
Inclusion Criteria2
- Age range: 50-80 years old.
- Undergoing MIS TLIF surgery at 1-2 spinal levels.
Exclusion Criteria4
- Previously undergone spine surgery.
- HbA1C greater than or equal to 7.5 mg%
- Allergic to all types of experimental medication.
- History of using systemic steroids.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DRUGDexamethasone
long-acting corticosteroid IV route
DRUGNormal saline
normal saline
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06367855
Related Trials
Neuralert Stroke Monitor Trial
NCT073623031 location
GRACE: Evaluating Compression Stockings in Patients That Require Extended Duration Pharmacological Thromboprophylaxis
NCT061665373 locations
INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
NCT072837831 location
Bleeding Reduction in Acute and Chronic Kidney Patients Having Surgery (BRACKETS) Pilot Trial
NCT063378382 locations
Implementation Pilot of Preoperative CGA Before Major Surgery
NCT061847241 location